Piombino Dese, Italy-based Stevanato Group’s agreement makes it an exclusive manufacturing partner for Owen Mumford’s Aidaptus auto-injector. Under the agreement, Stevanato Group will mold the components for the technology and provide final and sub-assembly equipment, along with market-leading pre-filled syringes.
Assembly for the components of the devices will be undertaken by both Stevanato Group at its global manufacturing sites and by Owen Mumford at its automated assembly center in the United Kingdom, according to a news release.
Owen Mumford designed the Aidaptus as a two-step, single-use auto-injector that accommodates both 1 mL and 2.25 mL prefilled glass syringes in the same basic device. It features plunger sensing technology with a self-adjusting plunger rod and can accommodate a wide variety of drug viscosities.
“Aidaptus will help patients to self-administer their individual therapies using a simple and easy-to-use device,” Owen Mumford Director Adam Mumford said in the release. “At the same time, this auto-injector can help reduce complexity, minimize supply chain risk and simplify final assembly for pharmaceutical and biotechnology companies, thanks to its ability to adapt to different viscosity, syringe sizes and fill volumes. Often during development or life-cycle management of injectable drug products, changes in these parameters can occur. Now for the first time, the device does not have to be changed as well.”
The companies will jointly launch the collaboration at Pharmapack Europe 2022 on May 18 and 19. Stevanato Group will present the Aidaptus system and its portfolio of integrated solutions at the event.
“We believe this agreement is an important step in enhancing and growing the opportunities in our drug delivery systems portfolio as we broaden our capabilities in this key market,” Stevanato Group Chief Business Officer Mauro Stocchi said. “As we are constantly working with our customers to satisfy their needs, we continue to experience an increase in demand for auto-injectors. With this agreement, we will exploit the full breadth of Stevanato Group integrated capabilities being able to offer device manufacturing, assembly equipment, together with pre-fillable syringes and inspection systems.”
